Skip Navigation
Welcome to Ostuka - people creating new products for better health worldwide
Japanese kanji, Pronounciation: Oh tsu-ka, Meaning: Major Milestone
Otsuka Facts
  • 87 companies, 27,000 employees worldwide.European operations in France, Germany, Italy, the Nordic region, Spain and the UK.
  • In 17 countries and regions across Asia-Pacific, the United States, Europe and the Middle East
  • 29 research centres worldwide
  • 70 manufacturing sites worldwide (in 10 countries)
  • Euro 5.3 billion in revenue annually (consolidated figures for FY 2005)
  • Overall R&D spend of €730 million (2005)
  • Ranked 26 out of the top 50 pharmaceutical companies in Pharmaceutical Executive Europe (July/August 2006 issue)
  • European operations in France, Germany, Italy, the Nordic region, Spain and the UK

This slideshow uses flash, if you do not have flash you can download it by clicking here.

Otsuka Europe

Otsuka Europe has a passion for improving the health of people in Europe. We are committed to focusing our research and development on innovative products and medical devices that address unmet medical needs, particularly in our specialist areas of cardiovascular, gastro-intestinal and central nervous system disorders.

Based on our corporate philosophy of 'Otsuka - people creating new products for better health worldwide' and inheriting the Otsuka ethos of creativity and actualisation, we focus our day to day efforts on putting into practice our maxim of 'only Otsuka can do it'.

Part of the Otsuka Pharmaceutical Group, a conglomerate of over 100 businesses established in 1921, Otsuka's European operation launched in 1982 with the opening of the Frankfurt Institute in Germany in 1982. We currently have sales and marketing operations in France, Germany,Italy the Nordic region, Spain and the UK, supported by the regional office of Otsuka Pharmaceutical Europe Limited, based in London.